+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peri-implantitis Market by Product Type, Treatment Modality, End User, Distribution Channel, Implant Material, Severity - Global Forecast to 2030- Product Image
Peri-implantitis Market by Product Type, Treatment Modality, End User, Distribution Channel, Implant Material, Severity - Global Forecast to 2030- Product Image
Sale

Peri-implantitis Market by Product Type, Treatment Modality, End User, Distribution Channel, Implant Material, Severity - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5205000
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Peri-implantitis is increasingly recognized as a significant concern within modern dentistry, influencing both clinical outcomes and the operational priorities of dental solution providers. As the need for advanced peri-implant disease management intensifies, industry leaders must navigate technical, regulatory, and economic dynamics to ensure sustained growth and competitiveness.

Peri-Implantitis Market Snapshot

The peri-implantitis market is expanding steadily, reflected in its robust size and continued momentum. Growing awareness of implant-related inflammatory conditions is fueling demand for specialized devices, pharmaceuticals, and surgical tools. Leading players are developing innovative diagnostic and therapeutic technologies, underpinning the market’s healthy compound annual growth rate (CAGR) and enabling a strong future outlook for stakeholders worldwide. North America, Europe, and Asia-Pacific are leading in adoption, supported by a blend of clinical research, technological advancement, and evolving healthcare infrastructure.

Scope & Segmentation

This comprehensive market research provides granular segmentation to help senior decision-makers evaluate investment and expansion opportunities across several dimensions:

  • Product Types: Adjunctive devices, laser treatment equipment, pharmacological therapies, and surgical solutions, including grafts and membranes.
  • Graft Types: Allograft, autograft, synthetic, and xenograft options, meeting diverse clinical needs.
  • Membrane Types: Resorbable and non-resorbable membranes, each offering unique advantages in periodontal regeneration.
  • Treatment Modalities: Non-surgical (e.g., local antibiotics, mechanical debridement) and surgical interventions (regenerative and resective procedures).
  • End Users: Ambulatory surgery centers, dental clinics, and hospitals—each adopting solutions based on procedural complexity and infrastructure.
  • Distribution Channels: Direct sales, distributor networks, and online procurement channels influencing accessibility and supply chain strategies.
  • Implant Materials: Titanium and zirconia implants, chosen for mechanical reliability or esthetic requirements.
  • Severity Levels: Solutions tailored for mild, moderate, and severe disease presentations.
  • Regional Analysis: In-depth coverage of the Americas (United States, Canada, Latin America), Europe, Middle East & Africa, and Asia-Pacific, including key sub-regions and leading economies.
  • Company Developments: Profiles of major medical device and biotech firms, highlighting innovations and commercial strategies shaping the competitive landscape.

Key Takeaways

  • Market growth is supported by heightened clinical demand, regulatory evolution, and regular introduction of advanced treatment solutions for peri-implantitis.
  • Technological convergence—especially laser-assisted therapies, digital workflow integration, and improved biomaterials—drives product differentiation and accelerates clinical adoption.
  • Collaboration among clinicians, manufacturers, and regulatory bodies is streamlining early diagnosis and optimizing intervention protocols, reducing patient morbidity and enhancing treatment efficacy.
  • Regional priorities differ; North America leverages established insurance coverage and healthy R&D pipelines, while Asia-Pacific’s surge in urbanization prompts investment in scalable, cost-effective solutions.
  • Stakeholders benefit by targeting emerging market segments, such as resorbable membranes and digital dentistry platforms, aligning with evolving clinician preferences.
  • Supply chain resilience, shaped by new sourcing and distribution partnerships, is an increasing focus in response to external cost pressures.

Tariff Impact

Recent tariffs on imported dental devices and materials have introduced new challenges for the U.S. peri-implantitis ecosystem. Elevated costs are leading manufacturers to consider domestic sourcing and localized partnerships. These shifts are creating new collaborations and prompting optimization of supply routes while driving investment in cost-efficient product designs. Innovative distribution models, such as direct-to-practice delivery and digital procurement, are helping stakeholders manage logistical expenses and remain competitive in the evolving tariff environment.

Methodology & Data Sources

This analysis employs a rigorous research approach, drawing on interviews with clinicians, executives, and opinion leaders, complemented by secondary reviews of journals, regulatory documents, and corporate disclosures. Quantitative insights are built from proprietary databases and validated through hierarchical classification and regional benchmarking.

Why This Report Matters

  • Facilitates informed decision-making by mapping actionable opportunities across product and regional segments within the peri-implantitis market.
  • Guides strategic planning and innovation through insights into technology trends, supply chain adaptation, and shifting reimbursement environments.
  • Equips senior executives with validated data to assess risk, target new markets, and allocate resources for sustainable growth in dental implant care.

Conclusion

This report offers a clear path to understanding the peri-implantitis market’s evolving landscape, enabling leaders to anticipate disruption and capture emerging value. With a foundation of robust research, stakeholders can drive better patient outcomes and long-term market performance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Peri-implantitis Market, by Product Type
8.1. Introduction
8.2. Adjunctive Devices
8.3. Laser Treatment
8.4. Pharmacological Treatment
8.5. Surgical Treatment
8.5.1. Graft Type
8.5.1.1. Allograft
8.5.1.2. Autograft
8.5.1.3. Synthetic
8.5.1.4. Xenograft
8.5.2. Membrane Type
8.5.2.1. Non-Resorbable
8.5.2.2. Resorbable
9. Peri-implantitis Market, by Treatment Modality
9.1. Introduction
9.2. Non Surgical
9.2.1. Local Antibiotic Therapy
9.2.2. Mechanical Debridement
9.3. Surgical
9.3.1. Regenerative Procedures
9.3.2. Resective Procedures
10. Peri-implantitis Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Dental Clinics
10.4. Hospitals
11. Peri-implantitis Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Channels
12. Peri-implantitis Market, by Implant Material
12.1. Introduction
12.2. Titanium
12.3. Zirconia
13. Peri-implantitis Market, by Severity
13.1. Introduction
13.2. Mild
13.3. Moderate
13.4. Severe
14. Americas Peri-implantitis Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Peri-implantitis Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Peri-implantitis Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Institut Straumann AG
17.3.2. DENTSPLY SIRONA Inc.
17.3.3. Zimmer Biomet Holdings, Inc.
17.3.4. Nobel Biocare Services AG
17.3.5. Osstem Implant Co., Ltd.
17.3.6. MIS Implants Technologies Ltd.
17.3.7. Geistlich Pharma AG
17.3.8. BioHorizons IPH, Inc.
17.3.9. CAMLOG Biotechnologies GmbH
17.3.10. Osteogenics Biomedical, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PERI-IMPLANTITIS MARKET MULTI-CURRENCY
FIGURE 2. PERI-IMPLANTITIS MARKET MULTI-LANGUAGE
FIGURE 3. PERI-IMPLANTITIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PERI-IMPLANTITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ADJUNCTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LASER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-RESORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY RESORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LOCAL ANTIBIOTIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MECHANICAL DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGENERATIVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY RESECTIVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MILD, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MODERATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. CANADA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. CANADA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 75. CANADA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 76. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 77. CANADA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. CANADA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. CANADA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 81. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 87. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 88. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 91. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 137. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 139. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 140. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 141. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 142. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 143. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 144. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 147. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 152. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 153. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 154. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 155. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 158. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 170. ITALY PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 172. ITALY PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 173. ITALY PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 174. ITALY PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 175. ITALY PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 176. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 177. ITALY PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. ITALY PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. ITALY PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 180. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 181. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 184. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 186. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 187. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 188. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 191. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 225. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 227. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 228. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 230. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 231. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 232. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 235. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 247. QATAR PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. QATAR PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 249. QATAR PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 250. QATAR PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 251. QATAR PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 252. QATAR PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 253. QATAR PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 254. QATAR PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. QATAR PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. QATAR PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 257. QATAR PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 258. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 260. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 261. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 262. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 263. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 264. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 265. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 268. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 291. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 293. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 294. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 295. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 296. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 297. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 298. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 301. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 302. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 304. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 305. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 306. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 307. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 308. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 309. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 312. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 324. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 326. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 327. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 328. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 329. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 330. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 331. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 334. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 335. POLAND PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 336. POLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 337. POLAND PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 338. POLAND PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 339. POLAND PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 340. POLAND PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 341. POLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 342. POLAND PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. POLAND PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. POLAND PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 345. POLAND PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 348. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2030 (USD MILLION)
TABLE 350. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 351. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 352. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 353. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 354. SWITZE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Peri-implantitis market report include:
  • Institut Straumann AG
  • DENTSPLY SIRONA Inc.
  • Zimmer Biomet Holdings, Inc.
  • Nobel Biocare Services AG
  • Osstem Implant Co., Ltd.
  • MIS Implants Technologies Ltd.
  • Geistlich Pharma AG
  • BioHorizons IPH, Inc.
  • CAMLOG Biotechnologies GmbH
  • Osteogenics Biomedical, Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.15 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.84 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Peri-implantitis Market Size, Share & Trends Analysis Report By Method Type, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Peri-implantitis Market Size, Share & Trends Analysis Report By Method Type, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Peri-implantitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Peri-implantitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Dental Laser Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Dental Laser Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Dental Implants & Abutments Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Dental Implants & Abutments Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 101 Pages
  • Global
From
Periodontal Dental Services Market by Service Type, Technology Integration, Indication, End-User - Global Forecast to 2030 - Product Image

Periodontal Dental Services Market by Service Type, Technology Integration, Indication, End-User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.